Search & Analyze
Popular Searches
Hester Biosciences Ltd.
Healthcare₹2,366.600.40%
24 Jul, 4:01 PM
CMP₹2,366.60
Mkt Cap₹2.01K Cr
P/E36.14
P/B5.58
ROE17.05%
52W High₹2,661.65
52W Low₹1,250.95
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
36.14
P/B Ratio
5.58
EV/EBITDA
22.76
Price/Sales
6.05
Dividend Yield (%)
0.47
EPS (TTM ₹)
65.40
Book Value (₹)
423.46
ROE (%)
17.05
ROCE (%)
16.21
ROA (%)
8.64
EBITDA Margin (%)
24.62
Net Profit Margin (%)
17.27
Debt/Equity
0.52
Current Ratio
1.37
Interest Coverage
7.94
Asset Turnover
0.50
Working Capital/Sales
5.93
Core EBITDA Growth (%)
48.27
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 2350.06 | 2660.91 | 3045.46 | 3111.02 | 3325.99 |
| Net Sales | 2350.06 | 2660.91 | 3045.46 | 3111.02 | 3325.99 |
| Total Income | 2487.47 | 2814.49 | 3156.74 | 3150.26 | 3470.05 |
| Total Expenditure | 1750.23 | 2156.89 | 2513.81 | 2500.5 | 2506.63 |
| Operating Profit | 737.24 | 657.6 | 642.93 | 649.76 | 963.42 |
| Depreciation | 165.81 | 206.95 | 171.74 | 168.02 | 188.81 |
| Exceptional Items | — | — | — | — | 29.36 |
| Profit Before Tax | 535.02 | 401.54 | 319.53 | 395.71 | 758.36 |
| Tax | 140.18 | 121.19 | 107.87 | 107.45 | 183.52 |
| Profit After Tax (PAT) | 394.84 | 280.35 | 211.66 | 288.26 | 574.84 |
| EPS (₹) | 46.41 | 32.96 | 24.88 | 33.89 | 67.57 |
| Dividend Payout % | 100 | 80 | 60 | 70 | 110 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 85.07 | 85.07 | 85.07 | 85.07 | 85.07 |
| Reserves | 2514.78 | 2712.23 | 2832.86 | 3057.48 | 3517.28 |
| Shareholders Funds | 2599.85 | 2797.3 | 2917.93 | 3142.55 | 3602.35 |
| Total Debt | 2225.71 | 2681.53 | 2390.42 | 2077.75 | 1882.55 |
| Total Liabilities | 5621.61 | 6699.66 | 6623.47 | 6533.85 | 6779.41 |
| Total Assets | 5621.61 | 6699.66 | 6623.47 | 6533.85 | 6779.41 |
| Book Value / Share | 305.613 | 328.8233 | 343.0034 | 369.4075 | 423.4572 |
| Assets | 5621.61 | 6699.66 | 6623.47 | 6533.85 | 6779.41 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 87.12 | 235.96 | 481.83 | 645.11 | 641.41 |
| Investing Activities | -1165.88 | -769.99 | -226.06 | -190.03 | -28.69 |
| Financing Activities | 1115.36 | 417.58 | -260.93 | -517.17 | -487.94 |
| Net Cash Flow | 36.6 | -116.45 | -5.16 | -62.09 | 124.78 |
HESTERBIO
₹2,366.60
+0.4%